Category Archives: Pharmaceuticals

Andi Karaboutis Drives Technology Innovation At Biogen Including The Internet Of Me

Andi Karaboutis, Vice President of Technology and Business Solutions at Biogen
Peter High again interviews Andi Karaboutis, former CIO of Dell, about her new role at Biogen, her rise to a post beyond CIO, her board appointment at Advance Auto Parts, and a variety of other topics.

Davíd Guzmán Makes H.D. Smith’s IT More Efficient Then Makes It A Source Of Revenue

David Guzman, Chief Information Officer of H.D. Smith
Peter High interviews David Guzman, CIO of H.D. Smith, discussing the strategic priorities of the organization, how “as-a-service” models will be the future of IT, as well as a variety of other topics.

CIO-Plus Series Summary in Forbes

This summary page provides access to the multi-part CIO-Plus series in Forbes
The CIO-Plus series in Forbes explores the trend of CIOs who are taking on more C-level titles. Most CIOs where many hats. The good news is, those hats are getting more strategic.

Richie Etwaru’s Ascent From CIO to CDO, by Peter High in CIO Insight Article

Cegedim RM Chief Digital Officer, Richie Etwaru discusses his career path, the role of Chief Digital Officer, and how he maintains his digital edge
Peter High, President of Metis Strategy, speaks with Richie Etwaru about the role of CDO, his career path, and his activities beyond the office

Forbes The CIO’s First 100 Days Series: Dale Danilewitz

The CIO’s First 100 Days: AmerisourceBergen
Dale Danilewitz, CIO of AmerisourceBergen discusses the importance of communication and understanding of IT and the business when leading a transformation in a CIO’s first 100 days.

Forbes CIO-plus Series: Chris Scalet, Merck

Former EVP of Global Services and Chief Information Officer- leading global business processes change
As the former EVP of Global Services and Chief Information of Merk, Chris Scalet oversaw the centralizing of IT, Human Resources, Finance, procurement, supply chain, and enterprise services, but the devil was in the details.